FindTrial
Sign In

Randomized controlled clinical trial of oral enteric-coated tablet of aspirin for primary liver cancer with portal vein tumor thrombosis surgery prevention of portal vein tumor thrombus recurrence efficacy

Randomized controlled clinical trial of oral enteric-coated tablet of aspirin for primary liver cancer with portal vein tumor thrombosis surgery prevention of portal vein tumor thrombus recurrence efficacy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003357
Enrollment
Unknown
Registered
2013-07-24
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer

Interventions

A:hepatectomy combined with oral enteric-coated tablet of aspirin
B:hepatectomy

Sponsors

Eastern Hepatobiliary Surgical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20 to 70 years old male or non-pregnant female hepatocellular carcinoma patient; 2. Portal vein tumor thrombus, I, II, III-type (Cheng SQ, et al. Hepato-Gastroenterology 2007; 54: 499-502); 3. Pathologically proved HCC, single tumor 1cm); 7. Prompt endoscopy colonoscopy without peptic ulcer disease; 8. Patients should sign the informed consent of this study.

Exclusion criteria

Exclusion criteria: 1. A history of long-term aspirin or aspirin allergy history; 2. Endoscopy, colonoscopy suggests the presence of a history of peptic ulcer; 3. History of bronchial asthma or chronic bleeding tendencies; 4. 30 days before enrollment received chemotherapy, radiotherapy, biological therapy, or participated in any other drug or therapy clinical trials by the instrument; 5. Liver, kidney and heart dysfunction; 6. Researchers believe that those who should not participate in this trial.

Design outcomes

Primary

MeasureTime frame
Overall survival;radiographic parameters;Liver function;—

Countries

China

Contacts

Public ContactCheng Shuqun
chengshuqun@yahoo.com+86 021-81875251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026